These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1296924)

  • 61. Cellular immune responses to cell wall peptidoglycan associated protein antigens in tuberculosis patients and healthy subjects.
    Dhiman N; Verma I; Khuller GK
    Microbiol Immunol; 1997; 41(6):495-502. PubMed ID: 9251061
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
    J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
    Gupta N; Vedi S; Kunimoto DY; Agrawal B; Kumar R
    Vaccine; 2016 Nov; 34(46):5677-5688. PubMed ID: 27693020
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human Interleukin-12p70 and Early Secretory Antigen Target-6 fusion protein.
    Deng Y; Bao L; Yang X
    Microbiol Immunol; 2011 Nov; 55(11):798-808. PubMed ID: 21831202
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosis.
    Dhar N; Rao V; Tyagi AK
    Med Microbiol Immunol; 2004 Feb; 193(1):19-25. PubMed ID: 12905016
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].
    Luo XD; Zhu DY; Chen Q; Jiang Y; Jiang S; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):611-6. PubMed ID: 15498274
    [TBL] [Abstract][Full Text] [Related]  

  • 67. DNA augments antigenicity of mycobacterial DNA-binding protein 1 and confers protection against Mycobacterium tuberculosis infection in mice.
    Matsumoto S; Matsumoto M; Umemori K; Ozeki Y; Furugen M; Tatsuo T; Hirayama Y; Yamamoto S; Yamada T; Kobayashi K
    J Immunol; 2005 Jul; 175(1):441-9. PubMed ID: 15972678
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.
    Brandt L; Skeiky YA; Alderson MR; Lobet Y; Dalemans W; Turner OC; Basaraba RJ; Izzo AA; Lasco TM; Chapman PL; Reed SG; Orme IM
    Infect Immun; 2004 Nov; 72(11):6622-32. PubMed ID: 15501795
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Proteoliposomes from Mycobacterium smegmatis induce immune cross-reactivity against Mycobacterium tuberculosis antigens in mice.
    Rodriguez L; Tirado Y; Reyes F; Puig A; Kadir R; Borrero R; Fernandez S; Reyes G; Alvarez N; Garcia MA; Sarmiento ME; Norazmi MN; Perez Quinoy JL; Acosta A
    Vaccine; 2011 Aug; 29(37):6236-41. PubMed ID: 21736914
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis.
    Hamasur B; Haile M; Pawlowski A; Schröder U; Williams A; Hatch G; Hall G; Marsh P; Källenius G; Svenson SB
    Vaccine; 2003 Sep; 21(25-26):4081-93. PubMed ID: 12922145
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adjuvant modulation of T-cell reactivity to 30-kDa secretory protein of Mycobacterium tuberculosis H37Rv and its protective efficacy against experimental tuberculosis.
    Sharma AK; Verma I; Tewari R; Khuller GK
    J Med Microbiol; 1999 Aug; 48(8):757-763. PubMed ID: 10450999
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice.
    Xu Y; Zhu B; Wang Q; Chen J; Qie Y; Wang J; Wang H; Wang B; Wang H
    FEMS Immunol Med Microbiol; 2007 Dec; 51(3):480-7. PubMed ID: 17919299
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The recombinant fusion protein CFP10-ESAT6-dIFN has protective effect against tuberculosis in guinea pigs.
    Permyakova NV; Belavin PA; Pirozhkova DS; Ufimtseva EG; Rozov SM; Mursalimov SR; Sidorchuk YV; Uvarova EA; Zagorskaya AA; Marenkova TV; Bannikova SV; Demidov EA; Starostin KV; Kravchenko MA; Vakhrusheva DV; Berdnikov RB; Eremeeva NI; Skornyakov SN; Peltek SE; Deineko EV
    Acta Microbiol Immunol Hung; 2018 Mar; 65(1):39-58. PubMed ID: 29243495
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
    Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
    APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Performance of Homologous and Heterologous Prime-Boost Immunization Regimens of Recombinant Adenovirus and Modified Vaccinia Virus Ankara Expressing an Ag85B-TB10.4 Fusion Protein against
    Kou Y; Wan M; Shi W; Liu J; Zhao Z; Xu Y; Wei W; Sun B; Gao F; Cai L; Jiang C
    J Microbiol Biotechnol; 2018 Jun; 28(6):1022-1029. PubMed ID: 29847865
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Humoral immune response against Salmonella typhimurium antigen fractions and protection.
    Calderon GM; Perez C; Ximenez C; Melendro EI
    Adv Exp Med Biol; 1995; 371B():1659-62. PubMed ID: 7502877
    [No Abstract]   [Full Text] [Related]  

  • 78. Immune gene networks of mycobacterial vaccine-elicited cellular responses and immunity.
    Huang D; Qiu L; Wang R; Lai X; Du G; Seghal P; Shen Y; Shao L; Halliday L; Fortman J; Shen L; Letvin NL; Chen ZW
    J Infect Dis; 2007 Jan; 195(1):55-69. PubMed ID: 17152009
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.
    Lahey T; Laddy D; Hill K; Schaeffer J; Hogg A; Keeble J; Dagg B; Ho MM; Arbeit RD; von Reyn CF
    PLoS One; 2016; 11(12):e0168521. PubMed ID: 27997597
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
    Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ
    Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.